ADHD Statistics in New York

Comprehensive ADHD statistics for New York, including prevalence, demographics, treatment access, and outcomes data.

4 min read
46.9%[1]
of children in New York with an ADHD diagnosis did not receive treatment

This highlights a significant gap between diagnosis and care for youth in the state, indicating potential barriers to accessing necessary services.

Key Takeaways

  • New York's childhood ADHD diagnosis rate of 13.3% is notably higher than the U.S. average, ranking it 15th highest among states.13.3%[1]
  • A significant treatment gap exists nationwide, with over a third (36.5%) of adults with ADHD receiving no treatment for their condition.36.5%[2]
  • Young adults aged 18-29 in New York show a higher ADHD prevalence (8%) compared to the national average for their age group (6%).8%[4]
  • Racial disparities in diagnosis are pronounced; Black individuals are often underdiagnosed with ADHD but overdiagnosed with disruptive behavior disorders like Conduct Disorder.[6]
  • Telehealth has become a critical tool for ADHD management, with nearly 46% of adults with the condition having used these services for their care.46%[2]
  • Socioeconomic factors, including economic hardship and lower parental education, are correlated with higher rates of ADHD diagnosis in children.[1]

Attention-Deficit/Hyperactivity Disorder (ADHD)

ADHD is one of the most common neurodevelopmental disorders, traditionally understood to have its onset in childhood. It is characterized by persistent patterns of inattention, hyperactivity, and impulsivity that interfere with functioning or development.

Source: Data and Statistics on ADHD. Centers for Disease Control and Prevention. Published 2022. Accessed January 2026. https://www.cdc.gov/adhd/data/index.html

ADHD Prevalence in New York and the U.S.

Understanding the prevalence of Attention-Deficit/Hyperactivity Disorder (ADHD) is the first step in addressing its impact on communities. Data reveals that New York has a higher rate of childhood ADHD diagnoses compared to the national average[1]. This trend extends to young adults as well, suggesting a significant population within the state requires access to diagnosis, treatment, and support services. Nationally, millions of children and adults are affected, making ADHD a major public health consideration[7].

Prevalence at a Glance

13.3%[1]
Children (3-17) ever diagnosed in New York
11.4%[7]
Children (3-17) ever diagnosed in the U.S.
2022
8%[4]
Young Adults (18-29) with ADHD in New York
6.0%[2]
U.S. Adults with a current ADHD diagnosis
2023
343,000[3]
Estimated people with ADHD in New York City

Includes 246,000 adults and 97,000 children and adolescents.

2023

State-by-State Variations

The prevalence of childhood ADHD is not uniform across the United States, with diagnosis rates varying significantly from one state to another. Rates can range from as low as 6% to as high as 16%[9]. This variation can be influenced by regional differences in diagnostic practices, access to healthcare, public awareness, and cultural factors. The following table illustrates how New York compares to states at both the high and low ends of the spectrum.

The ADHD Treatment Gap

While diagnosis is a crucial first step, access to effective treatment is what ultimately improves outcomes. Unfortunately, a substantial gap exists between the number of individuals diagnosed with ADHD and those who receive care. In New York, nearly half of children with a diagnosis do not receive treatment[1]. This issue is not unique to the state; nationally, about 30% of children and over 36% of adults with ADHD go untreated[7][2]. This gap can be attributed to factors like healthcare costs, insurance coverage limitations, provider shortages, and social stigma.

Treatment Landscape and Access

Diagnosed individuals in New York receiving continuous treatment in 2022
Americashealthrankings
32%[1]
U.S. children with ADHD who receive medication treatment
Centers for Disease Control and Prevention
62%[7]
U.S. adults with ADHD who have used telehealth services for their condition
PubMed Central (2023)
46%[2]
Density of ADHD-specific mental health providers in New York

This is higher than the national average of 10 per 100,000.

Nyc (2023)
15 per 100,000[3]

Demographics and Disparities in ADHD

ADHD does not affect all populations equally. Significant disparities exist across racial, ethnic, and gender lines, influencing everything from the likelihood of diagnosis to the type of care received. Research consistently shows that cultural factors, implicit bias in clinical settings, and systemic barriers can lead to underdiagnosis in some groups and misdiagnosis in others[6]. For example, in New York's public mental health system, Black children have greater odds of an ADHD diagnosis, while Hispanic children have lower odds compared to white children[2]. Understanding these demographic nuances is essential for creating equitable healthcare solutions.

Racial Disparities in Diagnosis

Diagnosis Patterns: Black vs. White Populations
61% higher
Conduct Disorder (CD) prevalence in Black population
55% lower
Inattentive ADHD prevalence in Black population
Opposite diagnostic trends
Studies show Black individuals are often underdiagnosed with inattentive ADHD but overdiagnosed with disruptive behavior disorders like CD and Oppositional Defiant Disorder (ODD) compared to White individuals. The mean age of diagnosis is also much earlier for Black patients (15.7 years) than for White patients (23.9 years).
Mental Health Treatment Engagement
60%
Non-Hispanic White Adults
42%
Racial/Ethnic Minority Adults
18-point gap in treatment access
This disparity in receiving any form of mental health treatment highlights systemic barriers that can disproportionately affect minority communities seeking care for conditions like ADHD.

Gender Differences in ADHD

Gender is one of the most significant factors in ADHD diagnosis. Males are diagnosed at a much higher rate than females, a trend that begins in early childhood[11]. This disparity may be due to differences in how ADHD symptoms present; hyperactive and impulsive behaviors, more common in boys, are often more disruptive and noticeable to parents and teachers. In contrast, inattentive symptoms, which can be more prevalent in girls, may be overlooked, leading to underdiagnosis in females across all racial groups[4].

The Gender Gap in Childhood Diagnosis

Cumulative ADHD Incidence by Age 12
6.4%
Boys
1.5%
Girls
Boys are over 4 times more likely to be diagnosed
Data from a large Finnish cohort study shows a dramatic difference in diagnosis rates by age 12. Male sex is considered a robust risk factor, with an adjusted odds ratio of approximately 4.6 for receiving an ADHD diagnosis.

Adult ADHD: Late Onset or Late Diagnosis?

While some studies estimate that 2.5% to 6.3% of adults may experience late-onset ADHD symptoms, researchers caution that many of these cases are likely instances of late identification of a childhood-onset disorder[17][5]. During childhood, symptoms can be masked by factors like a supportive family environment, high intelligence, or structured school settings[2]. These coping mechanisms can be overwhelmed during major life transitions, such as starting college or a demanding career, causing underlying ADHD symptoms to become apparent for the first time[14].

Perinatal and Environmental Risk Factors

Large-scale research has identified several factors associated with an increased risk of an ADHD diagnosis in children. These include maternal smoking during pregnancy (which can double the odds), maternal psychiatric disorders, single-parent status, and moderate preterm birth (32-36 weeks).

Outcomes and Co-occurring Conditions

The consequences of untreated ADHD can be serious and long-lasting, affecting academic performance, workplace productivity, and overall quality of life[18]. Individuals with unmanaged ADHD face increased risks of substance abuse, accidental injury, and co-occurring mental health conditions such as depression and anxiety[13][2]. The broader context of mental health in the U.S. is also relevant, with approximately 7.1% of adults affected by major depressive disorder and 18.8% of high school students reporting persistent feelings of sadness or hopelessness[12][19].

Frequently Asked Questions

Sources & References

All statistics and claims on this page are supported by peer-reviewed research and official government data sources.

1Explore ADD/ADHD Treatment - Children in New York | AHR. Americashealthrankings. Accessed January 2026. https://www.americashealthrankings.org/explore/measures/ADDtreat_overall/ADDtreat_aian/NY
2Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment, and .... NCBI. Published 2023. Accessed January 2026. https://pubmed.ncbi.nlm.nih.gov/39388378/
3New York City Releases Its First Ever State of Mental .... Nyc. Published 2023. Accessed January 2026. https://www.nyc.gov/site/doh/about/press/pr2024/nyc-releases-first-ever-state-of-mental-health-report.page
4ADHD Prevalence Among U.S. Children and Adolescents in 2022. PubMed Central. PMC11334226. Accessed January 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC11334226/
5State-based Prevalence of ADHD Diagnosis and .... Centers for Disease Control and Prevention. Published 2016. Accessed January 2026. https://www.cdc.gov/adhd/data/state-based-prevalence-of-adhd-diagnosis-and-treatment-2016-2019.html
6Large-scale analysis reveals racial disparities in the prevalence of .... Nature. Accessed January 2026. https://www.nature.com/articles/s41598-024-75954-5
7Data and Statistics on ADHD - CDC. Centers for Disease Control and Prevention. Accessed January 2026. https://www.cdc.gov/adhd/data/index.html
815.5 Million Adults Had Current ADHD Diagnosis in 2023. Thecardiologyadvisor. Published 2023. Accessed January 2026. https://www.thecardiologyadvisor.com/news/15-5-million-adults-had-current-adhd-diagnosis-in-2023/
9State ADHD Diagnosis & Treatment Prevalence 2016-2023 | CDC. Centers for Disease Control and Prevention. Published 2020. Accessed January 2026. https://www.cdc.gov/adhd/data/state-based-prevalence-of-adhd-diagnosis-and-treatment-2016-2019.html
10Population-Level Trends in Attention-Deficit/Hyperactivity Disorder .... JAMA Network. Published 2023. Accessed January 2026. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2842661
11General Prevalence of ADHD - CHADD. Chadd. Published 2024. Accessed January 2026. https://chadd.org/about-adhd/general-prevalence/
12[PDF] M ental H ealth in N ew York. National Alliance on Mental Illness. Published 2023. Accessed January 2026. https://www.nami.org/wp-content/uploads/2023/07/NewYorkStateFactSheet.pdf
13Danielson ML. ADHD Prevalence Among U.S. Children and Adolescents .... Tandfonline. Published 2024. doi:10.1080/15374416.2024.2335625. Accessed January 2026. https://www.tandfonline.com/doi/full/10.1080/15374416.2024.2335625
14A Qualitative Analysis of Contextual Factors Relevant to Suspected .... Researchgate. Accessed January 2026. https://www.researchgate.net/publication/332530095_A_Qualitative_Analysis_of_Contextual_Factors_Relevant_to_Suspected_Late-Onset_ADHD
15Prevalence of ADHD among children race U.S. 2023| Statista. Statista. Published 2023. Accessed January 2026. https://www.statista.com/statistics/1550461/prevalence-of-adhd-among-children-and-adolescents-race/?srsltid=AfmBOopFuwS5l0SdYZjZIJw3lUi7xVjWqGXbVaDyVUZ9btrOIGzliR6R
16Incidence of Attention‐Deficit/Hyperactivity Disorder Between 2016 .... Psychiatryonline. Published 2016. doi:10.1176/appi.prcp.20240121. Accessed January 2026. https://psychiatryonline.org/doi/10.1176/appi.prcp.20240121
17NSCH 2023: Prevalence of ADD or ADHD, Nationwide. Nschdata. Published 2023. Accessed January 2026. https://nschdata.org/browse/survey/results?q=11488&r=1
18In N. [PDF] 2023 Annual Report - Mayor's Office of Community Mental Health. Mentalhealth. Published 2017. Accessed January 2026. https://mentalhealth.cityofnewyork.us/wp-content/uploads/2023/02/2023-OCMH-Annual-Report.pdf
19Mental Health of Emerging Adults in New York City in 2023 | AJPH. Ajph. doi:10.2105/AJPH.2025.308163. Accessed January 2026. https://ajph.aphapublications.org/doi/10.2105/AJPH.2025.308163